Emergent BioSolutions Inc. (NYSE:EBS) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
SA Asks: How Will Changes at FDA Impact Vaccine Makers?
Emergent Biosolutions: Strategic Share Repurchase and Diversified Revenue Streams Signal Strong Buy Opportunity
Emergent BioSolutions Announces $50M Stock Repurchase Program
Express News | Emergent BioSolutions Inc - Authorizes $50 Million Stock Repurchase Program
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
H.C. Wainwright Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Maintains Target Price $15
Express News | HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target
Emergent BioSolutions Analyst Ratings
Independent Director Neal Fowler Sold A Bunch Of Shares In Emergent BioSolutions
Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
Express News | Hikma: Aims to Make Kloxxado Available via Prescription as Early as 2026
Express News | Hikma Announces Health Canada Approval of Kloxxado® (Naloxone Hcl) Nasal Spray 8 Mg
Hikma Announces Health Canada Approval of KLOXXADO (Naloxone HCl) Nasal Spray 8 Mg
Press Release: Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
Express News | Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
Emergent BioSolutions Announces $27M in Incremental Sales
Express News | Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers With Five Critical Medical Countermeasure Products